Leadership Team

The Neomatrix management board is comprised of pioneers and entrepreneurs in cancer immunology and gene therapy. Co-founders Dr. Luigi Aurisicchio and Dr. Fabio  Palombo are authors of numerous immunology and oncology publications.

Their experience in large industries such as MSD or academia provides a solid base for the advancement of personalized immunotherapy into clinical trials.

Finally, Prof. Carlo Ciliberto is an expert in artificial intelligence, which represent the new frontiers of prediction for the personalized cancer vaccine.